Swiss National Bank - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q3 2016$131,000
+28.4%
17,300
+38.4%
0.00%
Q2 2016$102,000
-25.0%
12,500
+14.7%
0.00%
Q1 2016$136,000
-19.5%
10,900
+29.8%
0.00%
Q4 2015$169,000
+65.7%
8,4000.0%0.00%
Q3 2015$102,000
-29.7%
8,400
+20.0%
0.00%
Q2 2015$145,0007,0000.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2016
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders